2016
DOI: 10.1016/j.neuropharm.2015.08.047
|View full text |Cite
|
Sign up to set email alerts
|

Molecular basis of toxicity of N-type calcium channel inhibitor MVIIA

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
40
1

Year Published

2017
2017
2024
2024

Publication Types

Select...
6
2
1

Relationship

1
8

Authors

Journals

citations
Cited by 34 publications
(42 citation statements)
references
References 36 publications
1
40
1
Order By: Relevance
“…Generally, a precipitating solvent is used to precipitate most proteins in plasma and keep the analytes in solution [ 24 , 28 , 29 ]. In the present assay, a mixed solvent of methanol/acetonitrile (50:50, v / v ) was used.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Generally, a precipitating solvent is used to precipitate most proteins in plasma and keep the analytes in solution [ 24 , 28 , 29 ]. In the present assay, a mixed solvent of methanol/acetonitrile (50:50, v / v ) was used.…”
Section: Discussionmentioning
confidence: 99%
“…These peptide conotoxins selectively target ion channels, e.g., Na + , K + and Ca 2+ channels, or membrane receptors (nAChR, NMDAR and G-protein-coupled receptors) [ 12 , 13 , 14 , 15 ]. For example, α-conotoxins GI, GIA and GII are potent antagonists for nicotine acetylcholine receptors (nAChRs) [ 16 , 17 , 18 ]; μ-conotoxins GIIIA, GIIIB and GIIIC selectively target sodium ion channels [ 19 , 20 , 21 ]; ω-conotoxins GVIA, GVIB, GVIC, GVIIA and GVIIB inhibit calcium ion channels [ 22 , 23 , 24 ]. GI ( Figure 1 ) contains 13 amino acid residues and two disulfide bridges and is the most poisonous of all the peptide toxins in the venom of C. geographus .…”
Section: Introductionmentioning
confidence: 99%
“…In December 2004, the Food and Drug Administration (FDA) approved Prialt ® (commercial name for MVIIA) for the treatment of severe chronic pain using an intrathecal pump system to deliver the drug into the cerebrospinal fluid. Consistent with this action, injection of MVIIA into mammals caused important neuromuscular effects such as decrease of spontaneous and coordinated locomotor activity and tremors [ 45 ]. It was shown that these effects and the pain relief caused by delivery of MVIIA into the cerebrospinal fluid are mediated by inhibition of the release of pro-nociceptive neurochemicals such as glutamate, calcitonin gene-related peptide (CGRP), and substance P into the brain and spinal cord [ 46 , 47 ].…”
Section: Classification Of ω-Conotoxins That Target Ca Vmentioning
confidence: 99%
“…However, although Prialt is approved for treating intractable cancer pain in humans it has a narrow therapeutic window and the potential for causing severe CNS side effects (Antanassoff et al, 2000;Penn and Paice, 2000;Miljanich, 2004;Staats et al, 2004;Thompson et al, 2006;Wallace et al, 2006;Ver et al, 2008). The toxicity of MVIIA has recently been attributed to a methionine residue at position 12 of the toxin molecule, which is known to dock to a hydrophobic binding pocket comprised of residues I300, F302, L305 of the Cav2.2 subunit (Wang et al, 2016).…”
Section: U-conotoxinsmentioning
confidence: 99%